Addition of Single Dose Gemtuzumab Ozogamicin to Intensive Induction Chemotherapy in Core-Binding Factor Acute Myeloid Leukemia

被引：0

作者：

Bourne, Garrett ^{[1
]}

Diebold, Kendall ^{[1
]}

Espinoza-Gutarra, Manuel ^{[2
]}

Al-Kadhimi, Zaid ^{[1
]}

Bachiashvili, Kimo ^{[2
]}

Rangaraju, Sravanti ^{[1
]}

Vachhani, Pankit ^{[3
]}

Bhatia, Ravi ^{[1
]}

Jamy, Omer ^{[4
]}

机构：

[1] Univ Alabama Birmingham, Birmingham, AL USA

[2] Univ Alabama Birmingham, ONeal Comprehens Canc Ctr, Birmingham, AL USA

[3] Univ Alabama Birmingham, ONeal Comprehens Canc Ctr, Div Hematol Oncol, Birmingham, AL USA

[4] Univ Alabama Birmingham, Div Hematol & Oncol, Dept Med, Birmingham, AL USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-189853

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[31] Prognosis and monitoring of core-binding factor acute myeloid leukemia: current and emerging factors
Duployez, Nicolas
Willekens, Christophe
Marceau-Renaut, Alice
Boudry-Labis, Elise
Preudhomme, Claude
EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (01) : 43 - 56
[32] Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implication
Jahn, Nikolaus
Terzer, Tobias
Straeng, Eric
Dolnik, Anna
Cocciardi, Sibylle
Panina, Ekaterina
Corbacioglu, Andrea
Herzig, Julia
Weber, Daniela
Schrade, Anika
Goetze, Katharina
Schroeder, Thomas
Luebbert, Michael
Wellnitz, Dominique
Koller, Elisabeth
Schlenk, Richard F.
Gaidzik, Verena, I
Paschka, Peter
Ruecker, Frank G.
Heuser, Michael
Thol, Felicitas
Ganser, Arnold
Benner, Axel
Doehner, Hartmut
Doehner, Konstanze
Bullinger, Lars
BLOOD ADVANCES, 2020, 4 (24) : 6342 - 6352
[33] The Clinical Implications and Outcomes of RAS Mutatome in Core-Binding Factor Acute Myeloid Leukemia
Awada, Hassan
Gurnari, Carmelo
Meggendorfer, Manja
Durmaz, Arda
Kuzmanovic, Teodora
Kerr, Cassandra
Carraway, Hetty
Nazha, Aziz
Haferlach, Torsten
Sekeres, Mikkael
Visconte, Valeria
Maciejewski, Jaroslaw
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S186 - S186
[34] Molecular Characterization of Relapsed Core-Binding Factor (CBF) Acute Myeloid Leukemia (AML)
Agrawal, Mridul
Corbacioglu, Andrea
Jahn, Nikolaus
Bullinger, Lars
Teleanu, Maria-Veronica
Gaidzik, Verena I.
Weber, Daniela
Goehring, Gudrun
Luebbert, Michael
Fiedler, Walter
Brossart, Peter
Kindler, Thomas
Radsak, Markus
Ringhoffer, Mark
Goetze, Katharina S.
Greil, Richard
Thol, Felicitas
Heuser, Michael
Ganser, Arnold
Schlenk, Richard F.
Doehner, Hartmut
Paschka, Peter
Doehner, Konstanze
BLOOD, 2015, 126 (23)
[35] Core-binding factor acute myeloid leukemia: can we improve on HiDAC consolidation?
Paschka, Peter
Doehner, Konstanze
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2013, : 209 - 219
[36] Long-term survival can be achieved in a significant fraction of older patients with core-binding factor acute myeloid leukemia treated with intensive chemotherapy
Mosna, Federico
Borlenghi, Erika
Litzow, Mark
Byrd, John C.
Papayannidis, Cristina
Tecchio, Cristina
Ferrara, Felicetto
Marcucci, Guido
Cairoli, Roberto
Morgan, Elizabeth A.
Gurrieri, Carmela
Yeung, Cecilia C. S.
Deeg, H. Joachim
Capelli, Debora
Candoni, Anna
Gotlib, Jason R.
Lunghi, Monia
Pullarkat, Sheeja
Lanza, Francesco
Galimberti, Sara
Forghieri, Fabio
Venditti, Adriano
Festuccia, Moreno
Audisio, Ernesta
Marvalle, Denise
Rigolin, Gian Matteo
Roti, Giovanni
Dibona, Eros
Visani, Giuseppe
Albano, Francesco
Eisfeld, Ann-Kathrin
Valent, Peter
Huls, Gerwin
Borthakur, Gautam
Krampera, Mauro
Martinelli, Giovanni
Kroeger, Nicolaus
Sperotto, Alessandra
Gottardi, Michele
HAEMATOLOGICA, 2025, 110 (03) : 608 - 620
[37] GEMTUZUMAB OZOGAMICIN FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA IN CHILDREN - SINGLE CENTER EXPERIENCE
Pawinska-Wasikowska, Katarzyna
Czogala, Malgorzata
Bukowska-Strakova, Karolina
Ksiazek, Teofila
Skoczen, Szymon
Balwierz, Walentyna
PEDIATRIC BLOOD & CANCER, 2022, 69 : S584 - S585
[38] The genomic landscape of core-binding factor acute myeloid leukemias
Zachary J Faber
Xiang Chen
Amanda Larson Gedman
Kristy Boggs
Jinjun Cheng
Jing Ma
Ina Radtke
Jyh-Rong Chao
Michael P Walsh
Guangchun Song
Anna K Andersson
Jinjun Dang
Li Dong
Yu Liu
Robert Huether
Zhongling Cai
Heather Mulder
Gang Wu
Michael Edmonson
Michael Rusch
Chunxu Qu
Yongjin Li
Bhavin Vadodaria
Jianmin Wang
Erin Hedlund
Xueyuan Cao
Donald Yergeau
Joy Nakitandwe
Stanley B Pounds
Sheila Shurtleff
Robert S Fulton
Lucinda L Fulton
John Easton
Evan Parganas
Ching-Hon Pui
Jeffrey E Rubnitz
Li Ding
Elaine R Mardis
Richard K Wilson
Tanja A Gruber
Charles G Mullighan
Richard F Schlenk
Peter Paschka
Konstanze Döhner
Hartmut Döhner
Lars Bullinger
Jinghui Zhang
Jeffery M Klco
James R Downing
Nature Genetics, 2016, 48 : 1551 - 1556
[39] The genomic landscape of core-binding factor acute myeloid leukemias
Faber, Zachary J.
Chen, Xiang
Gedman, Amanda Larson
Boggs, Kristy
Cheng, Jinjun
Ma, Jing
Radtke, Ina
Chao, Jyh-Rong
Walsh, Michael P.
Song, Guangchun
Andersson, Anna K.
Dang, Jinjun
Dong, Li
Liu, Yu
Huether, Robert
Call, Zhongling
Mulder, Heather
Wu, Gang
Edmonson, Michael
Rusch, Michael
Qu, Chunxu
Li, Yongjin
Vadodaria, Bhavin
Wang, Jianmin
Hedlund, Erin
Cao, Xueyuan
Yergeau, Donald
Nakitandwe, Joy
Pounds, Stanley B.
Shurtleff, Sheila
Fulton, Robert S.
Fulton, Lucinda L.
Easton, John
Parganas, Evan
Pui, Ching-Hon
Rubnitz, Jeffrey E.
Dingo, Li
Mardis, Elaine R.
Wilson, Richard K.
Gruber, Tanja A.
Mullighan, Charles G.
Schlenk, Richard F.
Paschka, Peter
Doehner, Konstanze
Doehner, Hartmut
Bullinger, Lars
Zhang, Jinghui
Klco, Jeffery M.
Downing, James R.
NATURE GENETICS, 2016, 48 (12) : 1551 - 1556
[40] The role of gemtuzumab ozogamicin in combination chemotherapy regimens for primary resistant or relapsed acute myeloid leukemia
Hien K. Duong
Matt Kalaycio
Current Hematologic Malignancy Reports, 2009, 4 (2) : 55 - 56

← 1 2 3 4 5 →